mhurhangee/ep-ind-claims huggingface dataset:
A method of fabricating an Organic Light Emitting Display (OLED), the method comprising: providing a substrate; applying a first electrode layer on the substrate; applying an organic layer pattern using the patterning method comprising the steps of: providing a donor substrate having an organic transfer layer; laminating the donor substrate and the substrate; and irradiating laser radiation onto a region of the donor substrate, which is to be transferred to form an organic layer pattern on the substrate, wherein the laser radiation is generated by a light source, a mask being arranged under the light source and a projection lens being arranged under the mask and applying a second electrode on the organic layer pattern, characterized in that the mask includes a first region having a Fresnel lens disposed at an edge of the mask to change an optical path of the laser radiation and a second region having no Fresnel lens such that the laser radiation irradiated onto an edge of the irradiated region has an energy density greater than that of the laser radiation irradiated onto other portions of the irradiated region; and wherein light irradiated onto the edge of the portion of the donor substrate through the first region of the mask overlaps a part of light irradiated onto the edge of the portion of the donor substrate through the second region of the mask. providing a substrate; applying a first electrode layer on the substrate; providing a donor substrate having an organic transfer layer; laminating the donor substrate and the substrate; and irradiating laser radiation onto a region of the donor substrate, which is to be transferred to form an organic layer pattern on the substrate, wherein the laser radiation is generated by a light source, a mask being arranged under the light source and a projection lens being arranged under the mask and applying a second electrode on the organic layer pattern,
An aqueous treatment mass, in particular emulsion treatment mass, for walls, ceilings or floors of buildings, in particular priming mass, containing at least one inorganic and/or organic binder, at least one thickener, in particular polyacrylate thickener, at least one substrate wetting additive and wherein the substrate wetting additive comprises at least one polyethersiloxane copolymer and/or at least one alkoxylated secondary alcohol and/or at least one alkoxylated linear or branched C9-C15 alcohol and is an amphiphilic substance which is capable of reducing the surface tension of aqueous liquid phases.
Method for controlling an electric motor of a power tool with a holder for a tool for unscrewing a screw from a mating piece, wherein, during unscrewing of a screw, the electric motor is stopped when the torque emitted by the electric motor falls below a prespecified limit value or when the screw has been unscrewed out of a seated position for a prespecified number of revolutions, wherein the torque is determined on the basis of a time profile of the current which is drawn by the electric motor when unscrewing the screw, and wherein the rotation speed of the electric motor is at least reduced when the current falls more rapidly than a time-based comparison gradient, characterized in that the comparison gradient can assume different values depending on a rotation speed of the electric motor prespecified by an operator and/or depending on a speed of an operation of a switch for prespecifying the rotation speed.
A protective shield for a pallet having an overall rectangular shape with height and width dimensions corresponding to those of a face of an industry standard pallet, where the industry standard pallet's dimensions are listed in ISO 6780, the shield defining one or more openings corresponding in size and relative position to the entry openings in the pallets' face when the shield is operatively abutted to the face; further, the shield openings having protrusions (111, 112, 113, 114) along at least portions of at least two sides, the protrusions extending into the corresponding entry opening in the face along at least two edges of the entry opening; characterized in that, at least a portion of one of the protrusions (111, 112, 113, 114) has an angled transition region (107, 108, 109, 110).
A method of wireless communication performed by a user equipment, UE, comprising: performing channel state information, CSI, measurements on one or more reference signal transmissions from a base station; determining, based at least in part on the CSI measurements, a set of non-zero linear combination complex coefficients for weighting and co-phasing for a linear combination of a plurality of frequency domain basis vectors and a plurality of spatial domain basis vectors; and transmitting a CSI feedback, wherein a first part of the CSI feedback includes at least an indication of a number of non-zero linear combination complex coefficients of the set of non-zero linear combination complex coefficients with regard to all layers of a communication link between the UE and the base station. performing channel state information, CSI, measurements on one or more reference signal transmissions from a base station; determining, based at least in part on the CSI measurements, a set of non-zero linear combination complex coefficients for weighting and co-phasing for a linear combination of a plurality of frequency domain basis vectors and a plurality of spatial domain basis vectors; and transmitting a CSI feedback, wherein a first part of the CSI feedback includes at least an indication of a number of non-zero linear combination complex coefficients of the set of non-zero linear combination complex coefficients with regard to all layers of a communication link between the UE and the base station.
A composition for optical materials, which comprises (a) a compound described below, (b) a compound described below, (c) a polyisocyanate and (d) a polythiol: the compound (a): a compound having the structure represented by the following formula: wherein m represents an integer from 0 to 4, and n represents an integer from 0 to 2; and the compound (b): a compound having the structure represented by the following formula: wherein m represents an integer from 0 to 4, and n represents an integer from 0 to 2, and wherein, when the total amount of the compound (a), the compound (b), the polyisocyanate (c) and the polythiol (d) is 100% by mass, the compound (a) is in an amount of 50 to 95% by mass; the compound (b) is in an amount of 0.05 to 20% by mass; the polyisocyanate (c) is in an amount of 1 to 25% by mass; and the polythiol (d) is in an amount of 1 to 25% by mass, and wherein the ratio of the SH groups in the polythiol (d) to the NCO groups in the polyisocyanate (c), i.e., [the number of the SH groups in the polythiol (d)/the number of the NCO groups in the polyisocyanate (c)] (SH group/NCO group) is 1.0 to 2.5. the compound (a): a compound having the structure represented by the following formula: wherein m represents an integer from 0 to 4, and n represents an integer from 0 to 2; and the compound (b): a compound having the structure represented by the following formula: wherein m represents an integer from 0 to 4, and n represents an integer from 0 to 2, and wherein, when the total amount of the compound (a), the compound (b), the polyisocyanate (c) and the polythiol (d) is 100% by mass, the compound (a) is in an amount of 50 to 95% by mass; the compound (b) is in an amount of 0.05 to 20% by mass; the polyisocyanate (c) is in an amount of 1 to 25% by mass; and the polythiol (d) is in an amount of 1 to 25% by mass, and wherein the ratio of the SH groups in the polythiol (d) to the NCO groups in the polyisocyanate (c), i.e., [the number of the SH groups in the polythiol (d)/the number of the NCO groups in the polyisocyanate (c)] (SH group/NCO group) is 1.0 to 2.5.
Use of a pulverulent, surface postcrosslinked polymer that absorbs water, aqueous or serous fluids and blood, formed from a) 55-99.9% by weight of polymerized, ethylenically unsaturated monomers that contain acid groups and have been neutralized to an extent of at least 25 mol%, b) 0-40% by weight of polymerized, ethylenically unsaturated monomers copolymerizable with a), c) 0.1-5.0% by weight of one or more polymerized crosslinkers, d) 0-30% by weight of a water-soluble polymer, where the sum total of the amounts by weight a) to d) is 100% by weight, as absorbent in nappies, sanitary towels or wound dressings, characterized in that the polymer is obtainable by coating the polymer with e) 0.01% to 5% by weight, based on the polymer, for at least one polyol as surface postcrosslinker in the form of an aqueous solution and with f) 0.001% to 0.5% by weight, based on the polymer, of a cation in the form of an aqueous solution, and heating to a postcrosslinking temperature of 150 to 300°C and - at a permeability of up to 70 · 10 -7 s cm 3 /g has a retention of at least 27 g/g, - at a permeability of > 70 to 150 · 10 -7 s cm 3 /g has a retention of at least 25 g/g. a) 55-99.9% by weight of polymerized, ethylenically unsaturated monomers that contain acid groups and have been neutralized to an extent of at least 25 mol%, b) 0-40% by weight of polymerized, ethylenically unsaturated monomers copolymerizable with a), c) 0.1-5.0% by weight of one or more polymerized crosslinkers, d) 0-30% by weight of a water-soluble polymer, where the sum total of the amounts by weight a) to d) is 100% by weight, as absorbent in nappies, sanitary towels or wound dressings, characterized in that the polymer is obtainable by coating the polymer with e) 0.01% to 5% by weight, based on the polymer, for at least one polyol as surface postcrosslinker in the form of an aqueous solution and with f) 0.001% to 0.5% by weight, based on the polymer, of a cation in the form of an aqueous solution, and heating to a postcrosslinking temperature of 150 to 300°C - at a permeability of up to 70 · 10 -7 s cm 3 /g has a retention of at least 27 g/g, - at a permeability of > 70 to 150 · 10 -7 s cm 3 /g has a retention of at least 25 g/g.
An in vitro method for diagnosing a brain tumour in a human test subject comprising: a. Determining the concentration of at least two metabolites comprised in a biofluid sample obtained from the human test subject, wherein said at least two metabolites are selected from the group consisting of: trimethylamine, trimethylamine- N -oxide (TMAO), taurine, creatine, phosphocreatine, uric acid, and creatinine; b. Comparing the concentration of the at least two metabolites in the biofluid sample with the concentration of the same at least two metabolites in at least one reference standard obtained from a non-tumour bearing subject; and c. Identifying a concentration difference for each of the at least two metabolites in the biofluid sample relative to the reference standard, wherein one or more of TMA, TMAO, taurine, creatine, and phosphocreatine is higher in concentration in the biofluid sample when compared to the reference standard, and/or wherein one or more of uric acid and creatinine is lower in concentration in the biofluid sample when compared to the reference standard; wherein the concentration difference for each of the at least two metabolites in the biofluid sample correlates with the presence of a brain tumour. a. Determining the concentration of at least two metabolites comprised in a biofluid sample obtained from the human test subject, wherein said at least two metabolites are selected from the group consisting of: trimethylamine, trimethylamine- N -oxide (TMAO), taurine, creatine, phosphocreatine, uric acid, and creatinine; b. Comparing the concentration of the at least two metabolites in the biofluid sample with the concentration of the same at least two metabolites in at least one reference standard obtained from a non-tumour bearing subject; and c. Identifying a concentration difference for each of the at least two metabolites in the biofluid sample relative to the reference standard, wherein one or more of TMA, TMAO, taurine, creatine, and phosphocreatine is higher in concentration in the biofluid sample when compared to the reference standard, and/or wherein one or more of uric acid and creatinine is lower in concentration in the biofluid sample when compared to the reference standard;
A medication delivery pen assembly comprising: a pen body for inserting therein a medical container having a septum; and a needle assembly having a hub connected to said pen body, a needle cannula extending through said hub having a distal end sharpened for insertion into a patient and a sharpened proximal end facilitating insertion into said septum, and a shield having a tubular portion telescopingly disposed about at least a portion of said hub, said tubular portion having an internal surface, a first projection extending inwardly from said internal surface, said shield being axially displaceable relatively along said hub distally from a first position, where said distal end of said needle cannula is exposed, to a second position, where said distal end of said needle cannula is enclosed by said shield so that distal-to-proximal movement of said shield relative to said hub is hindered by interengagement of said first projection and a portion of said hub, characterized in that said portion of said hub is an externally extending second projection which, upon said shield being manually displaced to said second position, is deflectibly urged past said first projection. a pen body for inserting therein a medical container having a septum; and a needle assembly having a hub connected to said pen body, a needle cannula extending through said hub having a distal end sharpened for insertion into a patient and a sharpened proximal end facilitating insertion into said septum, and a shield having a tubular portion telescopingly disposed about at least a portion of said hub, said tubular portion having an internal surface, a first projection extending inwardly from said internal surface, said shield being axially displaceable relatively along said hub distally from a first position, where said distal end of said needle cannula is exposed, to a second position, where said distal end of said needle cannula is enclosed by said shield so that distal-to-proximal movement of said shield relative to said hub is hindered by interengagement of said first projection and a portion of said hub, characterized in that said portion of said hub is an externally extending second projection which, upon said shield being manually displaced to said second position, is deflectibly urged past said first projection.
An apparatus comprising: a first aircraft system; a second aircraft system; a turbo-compressor including: a compressor having a compressor inlet suitable to be fluidly coupled to a low-pressure compressor of an aircraft engine and a compressor outlet fluidly coupled to said first aircraft system; and a turbine having a turbine inlet suitable to be fluidly coupled to a high-pressure compressor of the aircraft engine and a turbine outlet fluidly coupled to said second aircraft system; characterised in that the compressor outlet and turbine outlet are fluidly decoupled from one another. a first aircraft system; a second aircraft system; a turbo-compressor including: a compressor having a compressor inlet suitable to be fluidly coupled to a low-pressure compressor of an aircraft engine and a compressor outlet fluidly coupled to said first aircraft system; and a turbine having a turbine inlet suitable to be fluidly coupled to a high-pressure compressor of the aircraft engine and a turbine outlet fluidly coupled to said second aircraft system; a compressor having a compressor inlet suitable to be fluidly coupled to a low-pressure compressor of an aircraft engine and a compressor outlet fluidly coupled to said first aircraft system; and a turbine having a turbine inlet suitable to be fluidly coupled to a high-pressure compressor of the aircraft engine and a turbine outlet fluidly coupled to said second aircraft system;
Polymer composition comprising, as composition constituents Z1 at least 15% by weight, based on the polymer composition, of at least one thermoplastic polymer; Z2 from 0.001 to 15% by weight, based on the polymer composition, of a diester of a linear diol having from 2 to 8 carbon atoms with a linear or branched, saturated or unsaturated monocarboxylic acid having from 6 to 44 carbon atoms; and Z3 from 0.1 to 80% by weight, based on the polymer composition, of at least one pigment or of at least one filler or of a mixture thereof, wherein the amount of diesters having different fatty acid moieties on a diol is less than 10% by weight, based on the total amount of diester, or less than 8% by weight, based on the total amount of diester, and wherein the polymer is selected from the group consisting of polypropylene, polyethylene, polystyrene, polyether, polyisoprene and polybutadiene or copolymers of at least two of the above. Z1 at least 15% by weight, based on the polymer composition, of at least one thermoplastic polymer; Z2 from 0.001 to 15% by weight, based on the polymer composition, of a diester of a linear diol having from 2 to 8 carbon atoms with a linear or branched, saturated or unsaturated monocarboxylic acid having from 6 to 44 carbon atoms; and Z3 from 0.1 to 80% by weight, based on the polymer composition, of at least one pigment or of at least one filler or of a mixture thereof, wherein the amount of diesters having different fatty acid moieties on a diol is less than 10% by weight, based on the total amount of diester, or less than 8% by weight, based on the total amount of diester, and
A compound of Formula (I'): or a pharmaceutically acceptable salt or a stereoisomer thereof, wherein: ring A is azetidinyl, pyrrolidinyl or piperidinyl; X 1 is N; R 1 is methyl or halo; R 2 is C 1-4 alkyl, C 1-4 alkoxy, C 1-4 haloalkyl, C 1-4 haloalkoxy, C 3-6 cycloalkyl, C 3-6 cycloalkyl-C 1-2 alkyl-, OH, NH 2, -NH-C 1-4 alkyl, -N(C 1-4 alkyl) 2, 4- to 6-membered heterocycloalkyl or 4- to 6-membered heterocycloalkyl-C 1-2 alkyl-, wherein the 4- to 6-membered heterocycloalkyl and 4- to 6-membered heterocycloalkyl-C 1-2 alkyl- each has one or two heteroatoms as ring members selected from O and N, and wherein the C 1-4 alkyl, C 1-4 alkoxy, C 3-6 cycloalkyl, C 3-6 cycloalkyl-C 1-2 alkyl-, - NH-C 1-4 alkyl, -N(C 1-4 alkyl) 2, 4- to 6-membered heterocycloalkyl and 4- to 6-membered heterocycloalkyl-C 1-2 alkyl- of R 2 are each optionally substituted with 1 or 2 substituents independently selected from halo, CN and OH; R 3 is selected from -3-hydroxy-3-methylpyrrolidin-1-yl, -3-hydroxy-3-methylpyrrolidin-1-yl, -3-hydroxypyrrolidin-1-yl, -3-hydroxypyrrolidin-1-yl, -2-hydroxy-2-methyl-ethylamino, -2-hydroxy-2-methyl-ethylamino, -2-hydroxy-1-methyl-ethylamino and -2-hydroxy-1-methyl-ethylamino; R 4 is H or C 1-3 alkyl; and R 5 is C OH, C N(CH 3) 2, C NH(CH 3), or C NH(CH 2) 2 C OH. ring A is azetidinyl, pyrrolidinyl or piperidinyl; X 1 is N; R 1 is methyl or halo; R 2 is C 1-4 alkyl, C 1-4 alkoxy, C 1-4 haloalkyl, C 1-4 haloalkoxy, C 3-6 cycloalkyl, C 3-6 cycloalkyl-C 1-2 alkyl-, OH, NH 2, -NH-C 1-4 alkyl, -N(C 1-4 alkyl) 2, 4- to 6-membered heterocycloalkyl or 4- to 6-membered heterocycloalkyl-C 1-2 alkyl-, wherein the 4- to 6-membered heterocycloalkyl and 4- to 6-membered heterocycloalkyl-C 1-2 alkyl- each has one or two heteroatoms as ring members selected from O and N, and wherein the C 1-4 alkyl, C 1-4 alkoxy, C 3-6 cycloalkyl, C 3-6 cycloalkyl-C 1-2 alkyl-, - NH-C 1-4 alkyl, -N(C 1-4 alkyl) 2, 4- to 6-membered heterocycloalkyl and 4- to 6-membered heterocycloalkyl-C 1-2 alkyl- of R 2 are each optionally substituted with 1 or 2 substituents independently selected from halo, CN and OH; R 3 is selected from -3-hydroxy-3-methylpyrrolidin-1-yl, -3-hydroxy-3-methylpyrrolidin-1-yl, -3-hydroxypyrrolidin-1-yl, -3-hydroxypyrrolidin-1-yl, -2-hydroxy-2-methyl-ethylamino, -2-hydroxy-2-methyl-ethylamino, -2-hydroxy-1-methyl-ethylamino and -2-hydroxy-1-methyl-ethylamino; R 4 is H or C 1-3 alkyl; and R 5 is C OH, C N(CH 3) 2, C NH(CH 3), or C NH(CH 2) 2 C OH.
A transport refrigeration system comprising: a first sensor identified as required for operation of the transport refrigeration system; a second sensor operable as a backup for the first sensor; a third sensor identified as not required for operation of the transport refrigeration system; a first power supply operably connected to the first sensor and configured to operate the first sensor; a second power supply operably connected to the second sensor and configured to operate the second sensor; and a third power supply operably connected to the third sensor and configured to operate the third sensor; characterised by a controller operably connected to at least the first power supply as well as the first sensor and the second power supply as well as the second sensor, the controller configured to monitor at least the first power supply and the second power supply, if a fault is detected in the first power supply, operate the transport refrigeration system from the second sensor. a first sensor identified as required for operation of the transport refrigeration system; a second sensor operable as a backup for the first sensor; a third sensor identified as not required for operation of the transport refrigeration system; a first power supply operably connected to the first sensor and configured to operate the first sensor; a second power supply operably connected to the second sensor and configured to operate the second sensor; and a third power supply operably connected to the third sensor and configured to operate the third sensor; characterised by a controller operably connected to at least the first power supply as well as the first sensor and the second power supply as well as the second sensor, the controller configured to monitor at least the first power supply and the second power supply, if a fault is detected in the first power supply, operate the transport refrigeration system from the second sensor.
A composition comprising N-chlorotaurine or N,N-dichlorotaurine for use in treating or preventing a bronchopulmonary infection in a mammal, wherein N-chlorotaurine or N,N-dichlorotaurine is to be administered by inhalation.
BBU unit, "Base Band Unit", characterized in that it comprises means for connecting to a plurality of microwave heads (MW BBU), and in that it comprises means for providing any one of these microwave heads (MW BBU) with an identifier of this BBU unit, or for receiving from any one of these microwave heads (MW BBU) an identifier of an RRH unit, "Remote Radio Head", which identifier is contained in at least one predetermined control sub-channel of a signal for digital radio.
A method of transmitting to a second terminal data from a peripheral device (110, 120) connected to a first terminal in a communication network, wherein the peripheral device is a camera or a microphone the method comprising: receiving at the first terminal a data signal input from the peripheral device (110; 120) transmitting the data signal from the first terminal to the second terminal; and processing the data signal, characterised by determining an identity of the peripheral device (110, 120); supplying to a data store (108, 208) the identity of the peripheral device (110, 120); selecting from the data store (108, 208) at least one parameter based on the Identity of the peripheral device (110, 120); wherein the data signal is processed based on the selected parameter. receiving at the first terminal a data signal input from the peripheral device (110; 120) transmitting the data signal from the first terminal to the second terminal; and processing the data signal, characterised by determining an identity of the peripheral device (110, 120); supplying to a data store (108, 208) the identity of the peripheral device (110, 120); selecting from the data store (108, 208) at least one parameter based on the Identity of the peripheral device (110, 120); wherein the data signal is processed based on the selected parameter.